Abstract:Importance: Research is beginning to elucidate the sophisticated mechanisms underlying the microbiota-gut-brain-immune interface, moving from primarily animal models to human studies. Findings support the dynamic relationships between the gut microbiota as an ecosystem (microbiome) within an ecosystem (host) and its intersection with the host immune and nervous systems. Adding this to the effects on epigenetic regulation of gene expression further complicates and strengthens the response. At the heart is inflammation, which manifests in a variety of pathologies including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis (MS). Observations: Generally, the research to date is limited and has focused on bacteria, likely due to the simplicity and cost-effectiveness of 16s rRNA sequencing, despite its lower resolution and inability to determine functional ability/alterations. However, this omits all other microbiota including fungi, viruses, and phages, which are emerging as key members of the human microbiome. Much of the research has been done in pre-clinical models and/or in small human studies in more developed parts of the world. The relationships observed are promising but cannot be considered reliable or generalizable at this time. Specifically, causal relationships cannot be determined currently. More research has been done in Alzheimer's disease, followed by Parkinson's disease, and then little in MS. The data for MS is encouraging despite this. Conclusions and relevance: While the research is still nascent, the microbiota-gut-brain-immune interface may be a missing link, which has hampered our progress on understanding, let alone preventing, managing, or putting into remission neurodegenerative diseases. Relationships must first be established in humans, as animal models have been shown to poorly translate to complex human physiology and environments, especially when investigating the human gut microbiome and its relationships where animal models are often overly simplistic. Only then can robust research be conducted in humans and using mechanistic model systems.

The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases

The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature

The contribution of age-related changes in the gut-brain axis to neurological disorders

Healthy and Unhealthy Aging and the Human Microbiome

Aging Increases Markers of Inflammation and Alters Brain‐Gut Interactions

Influence of human gut microbiome on the healthy and the neurodegenerative aging

A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation

Gut microbiome and aging: Physiological and mechanistic insights

The aging gut microbiome and its impact on host immunity

Gut microbiota in multiple sclerosis and animal models

The human gut microbiome and aging

A Review of the Consequences of Gut Microbiota in Neurodegenerative Disorders and Aging

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions

Gut microbiota as the key controllers of “healthy” aging of elderly people

The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging

The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans

Ageing, proteostasis, and the gut: Insights into neurological health and disease

Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Age-associated changes in innate and adaptive immunity: role of the gut microbiota

Microbiota‐microglia connections in age‐related cognition decline

Revisiting Metchnikoff: Age-related alterations in microbiota-gut-brain axis in the mouse